Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer's pathology.

Maj M, Ilhan A, Neziri D, Gartner W, Berggard T, Attems J, Base W, Wagner L.

World J Diabetes. 2011 Apr 15;2(4):49-53. doi: 10.4239/wjd.v2.i4.49.

PMID:
21537460
[PubMed]
Free PMC Article
2.

Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62.

Jung HJ, Kim YJ, Eggert S, Chung KC, Choi KS, Park SA.

Exp Neurol. 2013 Oct;248:441-50. doi: 10.1016/j.expneurol.2013.07.013. Epub 2013 Jul 29.

PMID:
23906983
[PubMed - indexed for MEDLINE]
3.

A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models.

Park SA.

J Clin Neurol. 2011 Mar;7(1):10-8. doi: 10.3988/jcn.2011.7.1.10. Epub 2011 Mar 31.

PMID:
21519521
[PubMed]
Free PMC Article
4.

Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.

Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC.

Diabetes. 2004 Jun;53(6):1509-16.

PMID:
15161755
[PubMed - indexed for MEDLINE]
Free Article
5.

Genome-wide association studies: is there a genotype for cognitive decline in older persons with type 2 diabetes?

Abbatecola AM, Olivieri F, Corsonello A, Antonicelli R, Corica F, Lattanzio F.

Curr Pharm Des. 2011;17(4):347-56. Review.

PMID:
21352095
[PubMed - indexed for MEDLINE]
6.

Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.

Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM, Knuesel I.

J Neurosci. 2010 Jul 7;30(27):9228-40. doi: 10.1523/JNEUROSCI.0418-10.2010.

PMID:
20610758
[PubMed - indexed for MEDLINE]
Free Article
7.

Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.

Bitel CL, Kasinathan C, Kaswala RH, Klein WL, Frederikse PH.

J Alzheimers Dis. 2012;32(2):291-305. doi: 10.3233/JAD-2012-120571.

PMID:
22785400
[PubMed - indexed for MEDLINE]
10.

Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.

van de Nes JA, Nafe R, Schlote W.

Brain Res. 2008 Jun 5;1213:152-65. doi: 10.1016/j.brainres.2008.03.043. Epub 2008 Apr 1.

PMID:
18455153
[PubMed - indexed for MEDLINE]
11.

Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus.

Tiribuzi R, Orlacchio A, Crispoltoni L, Maiotti M, Zampolini M, De Angeliz M, Mecocci P, Cecchetti R, Bernardi G, Datti A, Martino S, Orlacchio A.

J Alzheimers Dis. 2011;24(4):785-97. doi: 10.3233/JAD-2011-100525.

PMID:
21321400
[PubMed - indexed for MEDLINE]
12.

Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.

Jung HJ, Park SS, Mok JO, Lee TK, Park CS, Park SA.

Exp Neurol. 2011 Apr;228(2):232-41. doi: 10.1016/j.expneurol.2011.01.012. Epub 2011 Jan 31.

PMID:
21281635
[PubMed - indexed for MEDLINE]
13.

Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease.

Chargé SB, Esiri MM, Bethune CA, Hansen BC, Clark A.

J Pathol. 1996 Aug;179(4):443-7.

PMID:
8869295
[PubMed - indexed for MEDLINE]
14.

Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.

Serrano-Pozo A, William CM, Ferrer I, Uro-Coste E, Delisle MB, Maurage CA, Hock C, Nitsch RM, Masliah E, Growdon JH, Frosch MP, Hyman BT.

Brain. 2010 May;133(Pt 5):1312-27. doi: 10.1093/brain/awq056. Epub 2010 Mar 31.

PMID:
20360050
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Beta-cell function and mass in type 2 diabetes.

Larsen MO.

Dan Med Bull. 2009 Aug;56(3):153-64.

PMID:
19728971
[PubMed - indexed for MEDLINE]
16.

Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers.

Attar A, Ripoli C, Riccardi E, Maiti P, Li Puma DD, Liu T, Hayes J, Jones MR, Lichti-Kaiser K, Yang F, Gale GD, Tseng CH, Tan M, Xie CW, Straudinger JL, Klärner FG, Schrader T, Frautschy SA, Grassi C, Bitan G.

Brain. 2012 Dec;135(Pt 12):3735-48. doi: 10.1093/brain/aws289. Epub 2012 Nov 26.

PMID:
23183235
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.

Imahori K, Uchida T.

J Biochem. 1997 Feb;121(2):179-88. Review.

PMID:
9089387
[PubMed - indexed for MEDLINE]
Free Article
18.

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.

PMID:
15977985
[PubMed - indexed for MEDLINE]
19.

beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.

Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE.

Diabetes. 2000 Dec;49(12):2056-62.

PMID:
11118007
[PubMed - indexed for MEDLINE]
20.

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.

Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, Moechars D, Van Leuven F.

Exp Gerontol. 2000 Sep;35(6-7):831-41. Review.

PMID:
11053674
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk